grovercentervetVeterinary diagnostics is the link between clinical observation and definitive medical action. In contrast to human health care, where initial disease detection depends upon the patient’s own assessment, veterinary medicine depends upon objective and quantifiable data for disease detection, physiological stress monitoring, and treatment efficacy assessment in different species.
Veterinary diagnostics is changing at a remarkable pace, ranging from fast, point-of-care (POC) handheld systems in mobile large animal units to high-throughput systems in the reference laboratory, which are powered by artificial intelligence and molecular technology. This chapter discusses the fundamental diagnostic modalities, the type of testing, handling of specimens, and some of the newer technologies which are influencing veterinary medicine today.
Core Pillars of In-Clinic Laboratory Diagnostics
Laboratory testing is the basic level of health screening, pre-anesthetic risk assessment, emergency triaging, and chronic disease management. The four main analytical fields used in an in-clinic diagnostic suite are haematology, clinical chemistry, urinalysis and parasitology.
Hematology and Hemostasis
Hematology tests are used to check the blood’s cellular components red blood cells (RBCs), white blood cells (WBCs), and platelets (PLTs). Complete blood counts (CBCs) are completed in minutes by automated analyzers (impedance or laser flow cytometry):
Red Blood Cell Indices: Hematocrit (HCT), Packed Cell Volume (PCV), Mean Corpuscular Volume (MCV), and Mean Corpuscular Hemoglobin Concentration (MCHC) differentiate between microcytic, macrocytic, regenerative and non-regenerative anemias.
Leukogram evaluation: White Blood Cell Differential – characterises neutrophils, lymphocytes, monocytes, eosinophils and basophils to identify acute systemic inflammation (e.g., left shift with band neutrophils) and stress leukograms or chronic immune reactions.
Primary and secondary hemostatic disorders such as disseminated intravascular coagulation (DIC) or rodenticide toxicity can be detected by a combination of quantitative platelet estimates and prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays.
Electrolyte disorders and clinical chemistry.
Biochemistry analyzers determine enzyme activities, metabolic end-products and electrolyte balance in serum or plasma:
Renal Profile: Blood urea nitrogen (BUN), serum creatinine, and symmetrical dimethylarginine (SDMA), a sensitive biomarker that detects early decreases in glomerular filtration rate (GFR) that may precede a decrease in serum creatinine.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are useful for the quantification of hepatocellular damage, while alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) are useful for the quantification of cholestasis/biliary disruption.
Electrolytes and Acid-Base Status: Sodium, potassium, chloride, and ionized calcium assess the hydration status, renal tubular function, and metabolic acidosis/alkalosis, respectively, in the critically ill patient.
Advanced Diagnostic Modalities: From Immunoassays to Molecular Diagnostics:
If abnormalities are detected in the baseline screening, then targeted diagnostic testing can locate specific etiologies, pathogens, or cellular mutations.
Immunodiagnostics and Enzyme-Linked Assays
Immunodiagnostics: antigen or antibody detection by means of enzyme-linked immunosorbent assays (ELISA), lateral-flow assays and indirect immunofluorescence assays (IFA):
Point of Care Infectious Disease Screening: Rapid lateral-flow tests are used for blood or saliva to detect feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), canine parvovirus (CPV) and vector-borne pathogens (such as Borrelia burgdorferi, Anaplasma, Ehrlichia, Dirofilaria immitis).
Endocrinology Panels: Quantitative immunoassays are used to diagnose metabolic diseases, such as hypothyroidism and Cushing’s disease, and include measurements of total cortisol (for ACTH stimulation and dexamethasone suppression testing) and canine thyroid-stimulating hormone (cTSH).
Molecular Diagnostics: PCR and Next-Generation Sequencing
Molecular testing can amplify sequences in the genome to a level of high specificity and sensitivity (high sensitivity), even at low loads of virus or bacteria:
Polymerase Chain Reaction (PCR): Real-time quantitative PCR (qPCR) panels can be used to detect pathogens, including those that are difficult to culture, such as Leptospira, Mycoplasma hemofelis, canine respiratory complex pathogens and equine herpesvirus (EHV-1).
Next-generation sequencing (NGS) can be used for comprehensive microbiome analysis, mutation detection of specific target genes (e.g. MDR1 gene mutation and drug clearance), and oncology profiling for targeted cancer treatment that matches tumour genotype.
2. Physical and Chemical Properties of Materials
Diagnostic imaging is a technique used to get a non-invasive picture of internal anatomic structures, spatial relationships and dynamic organ functions.
| Diagnostic Modality | Primary Applications | Strengths | Limitations |
|---|---|---|---|
| CT | Obstructive lung disease, trauma, and tumor detection and localization | Very rapid imaging, good for lung disease and tumor detection and localization | High radiation doses, poor for contrast resolution |
| Digital Radiography (DR) | Radiographic features of thoracic screening, bone fracture classification, gastrointestinal foreign bodies, dental pathology | Instantaneous image acquisition, lower radiation dose than film, DICOM export | 2D projection overlaid; poor soft-tissue contrast resolution |
| Ultrasonography (US) | Abdominal organ architecture, echocardiography, guided fine-needle aspirates (FNA) | No ionizing radiation, high soft-tissue detail | Operator dependent; blocked by bone and luminal air |
| Computed Tomography (CT) | Complex orthopedic planning, nasal cavity evaluation, pulmonary metastasizing screens | High-resolution 3D cross-sectional imaging, superior bone-tissue detail | Requires general anesthesia or deep sedation, higher equipment cost |
Tissue contrast (brain, spinal cord, soft-tissue joint structures, such as tendons and ligaments) is unmatched, and the signals transmitted are non-ionizing, magnetic RF, which is why MRI is used. Scan time is longer, and there are strict safety precautions to ensure the safety of the magnetic fields.
4. Diagnostic Sample Collection and Pre-Analytical Variable Management
The only thing that can be relied on as a diagnostic result is the quality of the sample that is submitted for testing. In veterinary laboratories, there are more than 60% of diagnostic discrepancies attributed to pre-analytical factors.
Factors That Interfere with Laboratory Test Results
1. Hemolysis: due to too much suction on the syringe, too small a needle gauge , or pushing the blood through the needle into a tube. Biochemistry panels falsely raise potassium, phosphorus and AST because of hemolysis.
Lipemia: High levels of circulating triglycerides after a meal interfere with the spectrophotometric analysis and give a falsely elevated hemoglobin, bilirubin, protein level. This risk may be reduced by fasting the patients for 8–12 hours before elective blood collection.
3. Icterus: increases in bilirubin lead to yellow (to dark amber) staining of the serum, which results in changes in optical density for automated enzymatic assays.
6. Connecting Artificial Intelligence and Point-of-Care (POC) systems.
Artificial intelligence (AI), machine learning, and cloud-based diagnostics are helping to speed up clinical workflows in veterinary practices.
In-Clinic Digital Cytology
POC DC devices enable physicians to transfer high-resolution images of FNAs, blood smears and ear cytology to cloud networks. AI algorithms pre-screen slides for neoplastic markers, inflammation and microorganisms and return annotated pathology summaries or allow quick consultation with board-certified veterinary pathologists.
AI-Driven Radiographic Interpretation
By leveraging millions of annotated DICOM images, machine learning models support clinicians in quickly identifying subtle abnormalities in the radiograph, such as early detection of pulmonary nodules, micro-fractures, heart enlargement, or abdominal fluid accumulation, thus decreasing diagnostic uncertainty in the emergency setting.
6. New species group diagnostic frameworks.
Modern veterinary diagnostics adjust to the patient, considers the patient’s signalment, usage and physiological differences between species groups.
Companion Animal Diagnostics (Dogs, Cats, Exotic Pets)
Preventive Screening Panels: These tests are included as part of a senior wellness program and are used to manage subclinical organ dysfunction proactively, including routine CBC, biochemistry and urine protein-to-creatinine (UPC) ratios and SDMA.
Microfluidic Point-of-Care Testing: Microfluidic cartridges can be used to reliably and safely perform routine diagnostic testing on small sample volumes, allowing diagnostic testing on birds, reptiles and small mammals such as ferrets and guinea pigs.
High-level Testing: of large animals and livestock. High-level surveillance of large animals and livestock. Allows disease monitoring and detection for continuous control of disease outbreaks such as BVD, Mastitis, and PRRS disease using automated bulk-tank milk PCR testing, pen-side lateral-flow immunoassay kits, and rapid oral-fluid pathogen panels.
On-Farm Diagnostic Infrastructure: Portable blood-gas analyzers and field-ready ultrasonography units enable ambulatory vets to do live metabolic and reproductive diagnostic testing at the farm.
Conclusion
The impact of veterinary diagnostics has changed the way care is provided in companion animal veterinary practices and commercial livestock management. With a comprehensive suite of laboratory tests, cutting-edge imaging, specific molecular diagnostics and AI-assisted point-of-care tests, vets can make accurate diagnoses in record time. Strict quality control during pre-analytical sample collection, keeping abreast of the latest advances in biomarker technology, and choosing the right diagnostic approach for each individual species is still at the heart of clinical excellence.
FAQ ( Frequently Asked Questions )
Q1. In veterinary medicine, what is the difference between complete blood count (CBC) and blood chemistry panels?
A Complete Blood Count (CBC) is a test of the cells in the blood such as red blood cells, white blood cells, and platelets, which can be used to detect conditions such as anemia, infection, inflammation and clotting disorders. The blood chemistry panel evaluates the blood chemistry, specifically the level of dissolved enzymes, electrolytes, proteins and metabolic waste products in the liquid part of the blood (plasma or serum) to check the function of the organs, including the liver and kidneys.
Q2. What is the benefit of SDMA testing to detect kidney disease early in cats and dogs?
Symmetrical dimethylarginine (SDMA) is a blood marker that can only be excreted by the kidneys, almost exclusively. It is able to identify renal impairment when the kidney function is only 25–40% reduced. By contrast, traditional blood markers, such as serum creatinine, usually aren’t raised until about 75% of the functional nephrons are injured.
Q3. What is the importance of pre-analytical sample handling in veterinary diagnostics?
Pre-analytical variables like the use of the wrong anticoagulant collection vessel, inadequate storage temperatures for the blood sample, and hemolysis of the sample during venipuncture can change the composition of a blood sample. These errors result in incorrect lab readings and can cause misdiagnosis or treatment plans or require repeated testing.
Q4. What is the meaning of point-of-care (POC) diagnostic tests and how would they be used in clinic?
Point-of-care (POC) diagnostic tests are diagnostic devices and rapid test kits used directly on-site for the patient (e.g., exam room, surgical suite, farm site). They perform rapid testing for parvovirus, heartworm disease, feline leukemia, glucose imbalances, and blood gas abnormalities, among other tests, without having to wait the time for off-site testing.
Q5. What role does artificial intelligence (AI) play in today’s veterinary imaging?
In veterinary imaging, AI algorithms can analyze digital X-rays, CT scans, and digital cytology slides to provide automated analysis and insights. They point out abnormalities, help with pattern recognition of diseases such as pulmonary nodules or fractures, and expedite diagnostic processes, improving turnaround times and diagnostic accuracy.
